Cardiol Therapeutics Inc. (TSX:CRDL,OTC:CRTPF) was featured in an article by Technical420 which covered the shift away from cannabis cultivation into a marketing, science and quality standards-based cannabis market and the company's efforts in meeting the new standards.
The post Cardiol is a Leader in Pharmaceutically Pure CBD appeared first on Investing News Network.
Original Article: Cardiol is a Leader in Pharmaceutically Pure CBD